Pulmozyme — United Healthcare

Initial criteria

• Diagnosis of cystic fibrosis
• Used in conjunction with standard CF therapies (e.g., chest physiotherapy, bronchodilators, antibiotics, anti-inflammatory therapy such as ibuprofen, oral/inhaled corticosteroids)

Reauthorization criteria

• Documentation of positive clinical response to Pulmozyme therapy

Approval duration

12 months